| ECM–receptor regulatory network and its prognostic role in colorectal cancer S Nersisyan, V Novosad, N Engibaryan, Y Ushkaryov, S Nikulin, ... Frontiers in Genetics 12, 782699, 2021 | 32 | 2021 |
| ExhauFS: exhaustive search-based feature selection for classification and survival regression S Nersisyan, V Novosad, A Galatenko, A Sokolov, G Bokov, A Konovalov, ... PeerJ 10, e13200, 2022 | 11 | 2022 |
| 9-ING-41, a small molecule inhibitor of GSK-3β, potentiates the effects of chemotherapy on colorectal cancer cells A Poloznikov, S Nikulin, L Bolotina, A Kachmazov, M Raigorodskaya, ... Frontiers in Pharmacology 12, 777114, 2021 | 3 | 2021 |
| Differences in Presentation of SARS-CoV-2 Omicron Strain Variant BA. 1–BA. 5 Peptides by HLA Molecules SA Nersisyan, MY Shkurnikov, AP Zhiyanov, VO Novosad, AG Tonevitsky Doklady Biochemistry and Biophysics 507 (1), 298-301, 2022 | 2 | 2022 |
| Spontaneous metastasis xenograft models link CD44 isoform 4 to angiogenesis, hypoxia, EMT and mitochondria‐related pathways in colorectal cancer A Everest‐Dass, S Nersisyan, H Maar, V Novosad, J Schröder‐Schwarz, ... Molecular Oncology 18 (1), 62-90, 2024 | 1 | 2024 |
| Identification of significant RNA-binding proteins in the process of CD44 splicing using the boosted beta regression algorithm VO Novosad Doklady Biochemistry and Biophysics 510 (1), 99-103, 2023 | 1 | 2023 |
| The RNA-binding proteins OAS1, ZFP36L2, and DHX58 are involved in the regulation of CD44 mRNA splicing in colorectal cancer cells VO Novosad, DV Maltseva Bulletin of Experimental Biology and Medicine 175 (1), 144-149, 2023 | 1 | 2023 |
| Expression of CD44 isoforms in human colorectal cancer cell lines MP Raigorodskaya, VO Novosad, SA Tonevitskaya, DV Maltseva Applied Biochemistry and Microbiology 58 (9), 992-996, 2022 | 1 | 2022 |
| Expression of CD44 isoforms in tumor samples and cell lines of human colorectal cancer VO Novosad, IS Polikanova, EA Tonevitsky, DV Maltseva Bulletin of Experimental Biology and Medicine 173 (1), 155-159, 2022 | 1 | 2022 |
